CA530054A - 2,4-diamino-5-benzylpyrimidines - Google Patents

2,4-diamino-5-benzylpyrimidines

Info

Publication number
CA530054A
CA530054A CA530054A CA530054DA CA530054A CA 530054 A CA530054 A CA 530054A CA 530054 A CA530054 A CA 530054A CA 530054D A CA530054D A CA 530054DA CA 530054 A CA530054 A CA 530054A
Authority
CA
Canada
Prior art keywords
benzylpyrimidines
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA530054A
Other languages
French (fr)
Inventor
A. Falco Elvira
H. Hitchings George
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Publication date
Priority to CA530054T priority Critical
Application granted granted Critical
Publication of CA530054A publication Critical patent/CA530054A/en
Expired legal-status Critical Current

Links

CA530054A 2,4-diamino-5-benzylpyrimidines Expired CA530054A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA530054T

Publications (1)

Publication Number Publication Date
CA530054A true CA530054A (en) 1956-09-04

Family

ID=35683803

Family Applications (1)

Application Number Title Priority Date Filing Date
CA530054A Expired CA530054A (en) 2,4-diamino-5-benzylpyrimidines

Country Status (1)

Country Link
CA (1) CA530054A (en)

Similar Documents

Publication Publication Date Title
CA527462A (en) 1-polyhalogeno-3,4-epoxybutanes
CA528609A (en) 4-pregnene-3,6,11,20-tetraone
CA524985A (en) 3,3,3-nitrilotrispropanamide
CA528619A (en) 21-acyloxy-4-pregnene-3,6,20-triones
CA528934A (en) 3,11-dihydroxy-16-pregnene-20-one
CA530054A (en) 2,4-diamino-5-benzylpyrimidines
CA531574A (en) 9 (11),16-bisdehydro-21-norprogesterone
CA532847A (en) 3,3'-bis-4-hydroxycoumarinylacetone
CA534295A (en) 1,8-dihydroxy-5-nitro-4-anilinoanthraquinone compounds
CA528532A (en) Dodecahydrophenanthrene-1,4,7-trione compounds
CA526197A (en) 1,5-dihydroxy-8-halo-4-aminoanthraquinone compounds
CA520549A (en) 2,2'-alkylidene-bis(6-alkyl-4-chlorophenols)
CA528268A (en) Steroid-11, 14-peroxides
CA535040A (en) D,l-dihydro-nor-lysergyl-glycinamide
CA520329A (en) Lithium 3-thia-7,7, dimethyl-7-tri-methylsiloxy-7-silaheptanoate
CA528616A (en) 17-hydroxy-4-pregnene-3,6,20-trione
AU211341B2 (en) 22528/56
CA527662A (en) 3.alpha.ACYLOXY-21,21-DIHYDROXY-11-20-DIKETO-12.alpha.-BROMOPREGNANE
CA527663A (en) 3.alpha.ACYLOXY-11,20-DIKETO-21,21-DIHYDROXY-12.alpha.-HALO-17.alpha.-BROMOPREGNANE
CA533211A (en) 3-acyloxy-5,7,9(11)-androstatrien-17-one adducts
CA551086A (en) 3,11-dihydroxypregnane-20-one-20-ketals
CA546857A (en) 9,10-anthracenediacetonitrile
CA537537A (en) 3,11,20-triketo-17-hydroxy-21-acetoxy-allopregnane
CA550933A (en) 9,10-anthracenedimethanol
CA551088A (en) Pregane-3,11,20-trione-3,20-diketals